Stocktoria
MEDICINOVA INC MNOV
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2006-12-01
MEDICINOVA INC statistics & valuation
Market cap$65.0M
P / B1.6×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -3242.5% | — | -990.0% | — | -253.0% |
| Net margin | -2928.8% | — | -857.2% | — | -251.0% |
| FCF margin | -2395.4% | — | -745.2% | — | -233.1% |
| Return on assets | -26.3% | -19.8% | -12.9% | -19.0% | -11.6% |
| Return on equity | -28.9% | -21.0% | -13.7% | -20.0% | -12.1% |
| Current ratio | 8.16 | 13.88 | 15.61 | 18.51 | 25.42 |
Source: SEC EDGAR filings · CIK 0001226616 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.